Ticlopidine versus oral anticoagulation for coronary stenting
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ticlopidine Versus Oral Anticoagulation for Coronary Stenting." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437571/all/Ticlopidine_versus_oral_anticoagulation_for_coronary_stenting:_Cochrane_systematic_review.
Ticlopidine versus oral anticoagulation for coronary stenting. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437571/all/Ticlopidine_versus_oral_anticoagulation_for_coronary_stenting:_Cochrane_systematic_review. Accessed January 19, 2026.
Ticlopidine versus oral anticoagulation for coronary stenting. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437571/all/Ticlopidine_versus_oral_anticoagulation_for_coronary_stenting:_Cochrane_systematic_review
Ticlopidine Versus Oral Anticoagulation for Coronary Stenting [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437571/all/Ticlopidine_versus_oral_anticoagulation_for_coronary_stenting:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ticlopidine versus oral anticoagulation for coronary stenting
ID - 437571
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437571/all/Ticlopidine_versus_oral_anticoagulation_for_coronary_stenting:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

